On May 7, 2021 KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, reported that the Company will host a conference call and live audio webcast on Thursday, May 13, 2021, at 4:30 p.m. ET, to discuss its corporate and financial results for the first quarter 2021 (Press release, KemPharm, MAY 7, 2021, View Source [SID1234579478]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Call Information:

Interested participants and investors may access the conference call by dialing either:

An audio webcast with slide presentation will be accessible via the Investor Relations section of the Company’s website, View Source An archive of the webcast and presentation will be available for 90 days beginning at approximately 5:30 p.m. ET, on May 13, 2021.

Investors may submit questions to KemPharm prior to the First Quarter 2021 Results conference call by e-mail to [email protected]. Please use the e-mail subject heading "KemPharm First Quarter 2021 Question" to ensure that the information is received. KemPharm’s management will then respond to select questions during the conference call.